Bonus BioGroup Ltd.
Bonus BioGroup Ltd. BBIXF Peers
See (BBIXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BBIXF | $0.05 | +50900.00% | 44B | -5.10 | -$0.01 | N/A |
| NONOF | $70.69 | +2.15% | 313.8B | 19.80 | $3.57 | +2.35% |
| CSLLY | $79.70 | +0.06% | 154.4B | 29.30 | $2.72 | +1.67% |
| CMXHF | $152.17 | -8.23% | 73.7B | 27.92 | $5.45 | +1.82% |
| UCBJY | $90.86 | +2.91% | 35.3B | 28.94 | $3.14 | +0.87% |
| ARGNF | $562.00 | N/A | 34.3B | 34.25 | $16.41 | N/A |
| UCBJF | $179.39 | +2.07% | 34.1B | 28.75 | $6.24 | +0.88% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| WXIBF | $3.20 | +6.67% | 13B | 29.09 | $0.11 | N/A |
| IVBXF | $7.81 | -1.74% | 12.9B | -780.64 | -$0.01 | N/A |
Stock Comparison
BBIXF vs NONOF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, NONOF has a market cap of 313.8B. Regarding current trading prices, BBIXF is priced at $0.05, while NONOF trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas NONOF's P/E ratio is 19.80. In terms of profitability, BBIXF's ROE is -2.10%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, BBIXF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CSLLY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CSLLY has a market cap of 154.4B. Regarding current trading prices, BBIXF is priced at $0.05, while CSLLY trades at $79.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CSLLY's P/E ratio is 29.30. In terms of profitability, BBIXF's ROE is -2.10%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, BBIXF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CMXHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CMXHF has a market cap of 73.7B. Regarding current trading prices, BBIXF is priced at $0.05, while CMXHF trades at $152.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CMXHF's P/E ratio is 27.92. In terms of profitability, BBIXF's ROE is -2.10%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, BBIXF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs UCBJY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, UCBJY has a market cap of 35.3B. Regarding current trading prices, BBIXF is priced at $0.05, while UCBJY trades at $90.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas UCBJY's P/E ratio is 28.94. In terms of profitability, BBIXF's ROE is -2.10%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, BBIXF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ARGNF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, BBIXF is priced at $0.05, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, BBIXF's ROE is -2.10%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, BBIXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs UCBJF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, UCBJF has a market cap of 34.1B. Regarding current trading prices, BBIXF is priced at $0.05, while UCBJF trades at $179.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas UCBJF's P/E ratio is 28.75. In terms of profitability, BBIXF's ROE is -2.10%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, BBIXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ODTC Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, BBIXF is priced at $0.05, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ODTC's P/E ratio is -0.08. In terms of profitability, BBIXF's ROE is -2.10%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, BBIXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs WXIBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, WXIBF has a market cap of 13B. Regarding current trading prices, BBIXF is priced at $0.05, while WXIBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas WXIBF's P/E ratio is 29.09. In terms of profitability, BBIXF's ROE is -2.10%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, BBIXF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs IVBXF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, IVBXF has a market cap of 12.9B. Regarding current trading prices, BBIXF is priced at $0.05, while IVBXF trades at $7.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas IVBXF's P/E ratio is -780.64. In terms of profitability, BBIXF's ROE is -2.10%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, BBIXF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GNMSF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GNMSF has a market cap of 12.8B. Regarding current trading prices, BBIXF is priced at $0.05, while GNMSF trades at $207.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GNMSF's P/E ratio is 12.20. In terms of profitability, BBIXF's ROE is -2.10%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, BBIXF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs WXXWY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, WXXWY has a market cap of 12.8B. Regarding current trading prices, BBIXF is priced at $0.05, while WXXWY trades at $6.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas WXXWY's P/E ratio is 26.16. In terms of profitability, BBIXF's ROE is -2.10%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, BBIXF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SBMFF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SBMFF has a market cap of 10B. Regarding current trading prices, BBIXF is priced at $0.05, while SBMFF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SBMFF's P/E ratio is 56.11. In terms of profitability, BBIXF's ROE is -2.10%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, BBIXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SBHMY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SBHMY has a market cap of 8.7B. Regarding current trading prices, BBIXF is priced at $0.05, while SBHMY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SBHMY's P/E ratio is 33.62. In terms of profitability, BBIXF's ROE is -2.10%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, BBIXF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs TRSBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, BBIXF is priced at $0.05, while TRSBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas TRSBF's P/E ratio is 21.67. In terms of profitability, BBIXF's ROE is -2.10%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, BBIXF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs TLPPF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, TLPPF has a market cap of 5.4B. Regarding current trading prices, BBIXF is priced at $0.05, while TLPPF trades at $16.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas TLPPF's P/E ratio is 178.07. In terms of profitability, BBIXF's ROE is -2.10%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, BBIXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ABCZF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, BBIXF is priced at $0.05, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, BBIXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ZLDPF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ZLDPF has a market cap of 5B. Regarding current trading prices, BBIXF is priced at $0.05, while ZLDPF trades at $70.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ZLDPF's P/E ratio is -26.69. In terms of profitability, BBIXF's ROE is -2.10%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, BBIXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs INCPF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, BBIXF is priced at $0.05, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas INCPF's P/E ratio is -108.67. In terms of profitability, BBIXF's ROE is -2.10%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, BBIXF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs AKBLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, BBIXF is priced at $0.05, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, BBIXF's ROE is -2.10%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, BBIXF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs LABFF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, BBIXF is priced at $0.05, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas LABFF's P/E ratio is 28.95. In terms of profitability, BBIXF's ROE is -2.10%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, BBIXF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs REGMF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, BBIXF is priced at $0.05, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas REGMF's P/E ratio is -13.32. In terms of profitability, BBIXF's ROE is -2.10%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, BBIXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GLPGF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, BBIXF is priced at $0.05, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GLPGF's P/E ratio is -15.66. In terms of profitability, BBIXF's ROE is -2.10%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, BBIXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CAMRF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CAMRF has a market cap of 3.1B. Regarding current trading prices, BBIXF is priced at $0.05, while CAMRF trades at $52.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CAMRF's P/E ratio is 54.49. In terms of profitability, BBIXF's ROE is -2.10%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, BBIXF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs TKBIF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, BBIXF is priced at $0.05, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, BBIXF's ROE is -2.10%, compared to TKBIF's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GNNSF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GNNSF has a market cap of 2.8B. Regarding current trading prices, BBIXF is priced at $0.05, while GNNSF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GNNSF's P/E ratio is -16.25. In terms of profitability, BBIXF's ROE is -2.10%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, BBIXF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs MPSYF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, BBIXF is priced at $0.05, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, BBIXF's ROE is -2.10%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, BBIXF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ASPHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, BBIXF is priced at $0.05, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, BBIXF's ROE is -2.10%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, BBIXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SHJBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SHJBF has a market cap of 2.1B. Regarding current trading prices, BBIXF is priced at $0.05, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, BBIXF's ROE is -2.10%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, BBIXF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BVNKF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BVNKF has a market cap of 2B. Regarding current trading prices, BBIXF is priced at $0.05, while BVNKF trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BVNKF's P/E ratio is 10.44. In terms of profitability, BBIXF's ROE is -2.10%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, BBIXF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BVNRY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BVNRY has a market cap of 2B. Regarding current trading prices, BBIXF is priced at $0.05, while BVNRY trades at $8.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BVNRY's P/E ratio is 10.06. In terms of profitability, BBIXF's ROE is -2.10%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, BBIXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SYGGF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SYGGF has a market cap of 2B. Regarding current trading prices, BBIXF is priced at $0.05, while SYGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SYGGF's P/E ratio is -0.47. In terms of profitability, BBIXF's ROE is -2.10%, compared to SYGGF's ROE of -0.62%. Regarding short-term risk, BBIXF is more volatile compared to SYGGF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BTTAY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, BBIXF is priced at $0.05, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, BBIXF's ROE is -2.10%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, BBIXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs MEOBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, BBIXF is priced at $0.05, while MEOBF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas MEOBF's P/E ratio is -16.05. In terms of profitability, BBIXF's ROE is -2.10%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, BBIXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GENSF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, BBIXF is priced at $0.05, while GENSF trades at $26.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GENSF's P/E ratio is -332.47. In terms of profitability, BBIXF's ROE is -2.10%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, BBIXF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BRCTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, BBIXF is priced at $0.05, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BRCTF's P/E ratio is 17.68. In terms of profitability, BBIXF's ROE is -2.10%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, BBIXF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PHMMF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, BBIXF is priced at $0.05, while PHMMF trades at $93.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PHMMF's P/E ratio is 72.57. In terms of profitability, BBIXF's ROE is -2.10%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, BBIXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BIESF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, BBIXF is priced at $0.05, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BIESF's P/E ratio is -44.44. In terms of profitability, BBIXF's ROE is -2.10%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, BBIXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ONTTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, BBIXF is priced at $0.05, while ONTTF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ONTTF's P/E ratio is -7.65. In terms of profitability, BBIXF's ROE is -2.10%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, BBIXF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PPTDF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, BBIXF is priced at $0.05, while PPTDF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PPTDF's P/E ratio is 15.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, BBIXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CSBTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, BBIXF is priced at $0.05, while CSBTF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CSBTF's P/E ratio is -266.67. In terms of profitability, BBIXF's ROE is -2.10%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, BBIXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs NURPF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, BBIXF is priced at $0.05, while NURPF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas NURPF's P/E ratio is 11.67. In terms of profitability, BBIXF's ROE is -2.10%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, BBIXF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SNBIF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SNBIF has a market cap of 926.4M. Regarding current trading prices, BBIXF is priced at $0.05, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, BBIXF's ROE is -2.10%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, BBIXF is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ASCLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ASCLF has a market cap of 904M. Regarding current trading prices, BBIXF is priced at $0.05, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ASCLF's P/E ratio is -23.31. In terms of profitability, BBIXF's ROE is -2.10%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, BBIXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PHGUF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PHGUF has a market cap of 680.3M. Regarding current trading prices, BBIXF is priced at $0.05, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, BBIXF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BPMUF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BPMUF has a market cap of 636.6M. Regarding current trading prices, BBIXF is priced at $0.05, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BPMUF's P/E ratio is 7.30. In terms of profitability, BBIXF's ROE is -2.10%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, BBIXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs INRLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, BBIXF is priced at $0.05, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas INRLF's P/E ratio is -5.08. In terms of profitability, BBIXF's ROE is -2.10%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, BBIXF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SOLTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SOLTF has a market cap of 534.2M. Regarding current trading prices, BBIXF is priced at $0.05, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, BBIXF's ROE is -2.10%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, BBIXF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs IVEVF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, IVEVF has a market cap of 505.9M. Regarding current trading prices, BBIXF is priced at $0.05, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, BBIXF's ROE is -2.10%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, BBIXF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CLTEF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, BBIXF is priced at $0.05, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, BBIXF's ROE is -2.10%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, BBIXF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BXPHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BXPHF has a market cap of 489.2M. Regarding current trading prices, BBIXF is priced at $0.05, while BXPHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BXPHF's P/E ratio is -24.95. In terms of profitability, BBIXF's ROE is -2.10%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, BBIXF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CKDXF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CKDXF has a market cap of 475.3M. Regarding current trading prices, BBIXF is priced at $0.05, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, BBIXF's ROE is -2.10%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, BBIXF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs VBIZF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, VBIZF has a market cap of 473M. Regarding current trading prices, BBIXF is priced at $0.05, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, BBIXF's ROE is -2.10%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, BBIXF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs MDCLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, MDCLF has a market cap of 463M. Regarding current trading prices, BBIXF is priced at $0.05, while MDCLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, BBIXF's ROE is -2.10%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, BBIXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs AAVXF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, BBIXF is priced at $0.05, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas AAVXF's P/E ratio is -2.26. In terms of profitability, BBIXF's ROE is -2.10%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, BBIXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs RAONF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, BBIXF is priced at $0.05, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas RAONF's P/E ratio is -43.33. In terms of profitability, BBIXF's ROE is -2.10%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, BBIXF is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BOVNF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, BBIXF is priced at $0.05, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BOVNF's P/E ratio is -12.05. In terms of profitability, BBIXF's ROE is -2.10%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, BBIXF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CSPHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, BBIXF is priced at $0.05, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, BBIXF's ROE is -2.10%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, BBIXF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs TBGNF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, BBIXF is priced at $0.05, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, BBIXF's ROE is -2.10%, compared to TBGNF's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CYDY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CYDY has a market cap of 418.8M. Regarding current trading prices, BBIXF is priced at $0.05, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CYDY's P/E ratio is -16.99. In terms of profitability, BBIXF's ROE is -2.10%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, BBIXF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs HBMHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, HBMHF has a market cap of 407.9M. Regarding current trading prices, BBIXF is priced at $0.05, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, BBIXF's ROE is -2.10%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, BBIXF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GSGTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GSGTF has a market cap of 403.2M. Regarding current trading prices, BBIXF is priced at $0.05, while GSGTF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, BBIXF's ROE is -2.10%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, BBIXF is more volatile compared to GSGTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PTCHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PTCHF has a market cap of 396.3M. Regarding current trading prices, BBIXF is priced at $0.05, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, BBIXF's ROE is -2.10%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, BBIXF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs NWBO Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, NWBO has a market cap of 392.6M. Regarding current trading prices, BBIXF is priced at $0.05, while NWBO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas NWBO's P/E ratio is -4.54. In terms of profitability, BBIXF's ROE is -2.10%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, BBIXF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CLVLY Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CLVLY has a market cap of 357.9M. Regarding current trading prices, BBIXF is priced at $0.05, while CLVLY trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CLVLY's P/E ratio is 14.28. In terms of profitability, BBIXF's ROE is -2.10%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, BBIXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CLVLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CLVLF has a market cap of 348.4M. Regarding current trading prices, BBIXF is priced at $0.05, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CLVLF's P/E ratio is 13.90. In terms of profitability, BBIXF's ROE is -2.10%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, BBIXF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs HLOSF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, BBIXF is priced at $0.05, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas HLOSF's P/E ratio is -9.91. In terms of profitability, BBIXF's ROE is -2.10%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, BBIXF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs IDRSF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, IDRSF has a market cap of 305.7M. Regarding current trading prices, BBIXF is priced at $0.05, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas IDRSF's P/E ratio is -0.91. In terms of profitability, BBIXF's ROE is -2.10%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, BBIXF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PBBIF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, BBIXF is priced at $0.05, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, BBIXF's ROE is -2.10%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, BBIXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PRRUF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PRRUF has a market cap of 283.3M. Regarding current trading prices, BBIXF is priced at $0.05, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PRRUF's P/E ratio is -9.70. In terms of profitability, BBIXF's ROE is -2.10%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, BBIXF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs NGENF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, NGENF has a market cap of 281.8M. Regarding current trading prices, BBIXF is priced at $0.05, while NGENF trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas NGENF's P/E ratio is -13.89. In terms of profitability, BBIXF's ROE is -2.10%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, BBIXF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs GNFTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, GNFTF has a market cap of 276.3M. Regarding current trading prices, BBIXF is priced at $0.05, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, BBIXF's ROE is -2.10%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, BBIXF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs IPHYF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, IPHYF has a market cap of 267.3M. Regarding current trading prices, BBIXF is priced at $0.05, while IPHYF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas IPHYF's P/E ratio is -4.20. In terms of profitability, BBIXF's ROE is -2.10%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, BBIXF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs TRGNF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, TRGNF has a market cap of 263.9M. Regarding current trading prices, BBIXF is priced at $0.05, while TRGNF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas TRGNF's P/E ratio is -6.06. In terms of profitability, BBIXF's ROE is -2.10%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, BBIXF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs OPORF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, BBIXF is priced at $0.05, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas OPORF's P/E ratio is 17.50. In terms of profitability, BBIXF's ROE is -2.10%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, BBIXF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs AVCTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, AVCTF has a market cap of 239M. Regarding current trading prices, BBIXF is priced at $0.05, while AVCTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, BBIXF's ROE is -2.10%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, BBIXF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ORYZF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, BBIXF is priced at $0.05, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, BBIXF's ROE is -2.10%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, BBIXF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs NWPHF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, BBIXF is priced at $0.05, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas NWPHF's P/E ratio is N/A. In terms of profitability, BBIXF's ROE is -2.10%, compared to NWPHF's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SLNCF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SLNCF has a market cap of 225.3M. Regarding current trading prices, BBIXF is priced at $0.05, while SLNCF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SLNCF's P/E ratio is -3.12. In terms of profitability, BBIXF's ROE is -2.10%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, BBIXF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs HNSBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, HNSBF has a market cap of 223.8M. Regarding current trading prices, BBIXF is priced at $0.05, while HNSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas HNSBF's P/E ratio is -2.58. In terms of profitability, BBIXF's ROE is -2.10%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, BBIXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SPHDF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SPHDF has a market cap of 211.7M. Regarding current trading prices, BBIXF is priced at $0.05, while SPHDF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SPHDF's P/E ratio is -3.66. In terms of profitability, BBIXF's ROE is -2.10%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, BBIXF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs FPHAF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, BBIXF is priced at $0.05, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, BBIXF's ROE is -2.10%, compared to FPHAF's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs VSBC Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, BBIXF is priced at $0.05, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas VSBC's P/E ratio is N/A. In terms of profitability, BBIXF's ROE is -2.10%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, BBIXF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs FGHQF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, BBIXF is priced at $0.05, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, BBIXF's ROE is -2.10%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, BBIXF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs AMGXF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, AMGXF has a market cap of 190.7M. Regarding current trading prices, BBIXF is priced at $0.05, while AMGXF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, BBIXF's ROE is -2.10%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, BBIXF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs CMVLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, BBIXF is priced at $0.05, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, BBIXF's ROE is -2.10%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, BBIXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BSEM Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BSEM has a market cap of 182.2M. Regarding current trading prices, BBIXF is priced at $0.05, while BSEM trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BSEM's P/E ratio is -19.56. In terms of profitability, BBIXF's ROE is -2.10%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, BBIXF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs SCNLF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, BBIXF is priced at $0.05, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, BBIXF's ROE is -2.10%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, BBIXF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs RECEF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, BBIXF is priced at $0.05, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas RECEF's P/E ratio is -10.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, BBIXF is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs MLLCF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, BBIXF is priced at $0.05, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas MLLCF's P/E ratio is -2.04. In terms of profitability, BBIXF's ROE is -2.10%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, BBIXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PBIGF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PBIGF has a market cap of 140.2M. Regarding current trading prices, BBIXF is priced at $0.05, while PBIGF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PBIGF's P/E ratio is -12.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, BBIXF is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs BRIBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, BBIXF is priced at $0.05, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, BBIXF's ROE is -2.10%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, BBIXF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs HOFBF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, BBIXF is priced at $0.05, while HOFBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to HOFBF's ROE of -1.07%. Regarding short-term risk, BBIXF is more volatile compared to HOFBF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs AAPGV Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, BBIXF is priced at $0.05, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas AAPGV's P/E ratio is N/A. In terms of profitability, BBIXF's ROE is -2.10%, compared to AAPGV's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PRNAF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, BBIXF is priced at $0.05, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, BBIXF's ROE is -2.10%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, BBIXF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs PSTTF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, BBIXF is priced at $0.05, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to PSTTF's ROE of N/A. Regarding short-term risk, BBIXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs EPRXF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, BBIXF is priced at $0.05, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, BBIXF's ROE is -2.10%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, BBIXF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs MMIRF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, MMIRF has a market cap of 106.3M. Regarding current trading prices, BBIXF is priced at $0.05, while MMIRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas MMIRF's P/E ratio is -7.00. In terms of profitability, BBIXF's ROE is -2.10%, compared to MMIRF's ROE of +0.24%. Regarding short-term risk, BBIXF is more volatile compared to MMIRF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs IUGNF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, IUGNF has a market cap of 104.5M. Regarding current trading prices, BBIXF is priced at $0.05, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas IUGNF's P/E ratio is -1.40. In terms of profitability, BBIXF's ROE is -2.10%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, BBIXF is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.
BBIXF vs ADOIF Comparison
BBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBIXF stands at 44B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, BBIXF is priced at $0.05, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBIXF currently has a P/E ratio of -5.10, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, BBIXF's ROE is -2.10%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, BBIXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for BBIXF.